Peter Attia· MD
the glp1 receptor Agonist what I'm doing is I'm giving you a pharmacological dose of glp1 and I'm overcoming the resistance at the level of the beta cell
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the glp1 receptor Agonist what I'm doing is I'm giving you a pharmacological dose of glp1 and I'm overcoming the resistance at the level of the beta cell
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
makes sense if that's the case that giving exogenous GLP1. You take a shot of tzepide or semiglutide, you're going to put more GLP-1 in the system. You're going to overcome the resistance at the beta cell. You make more insulin. You now have better glucose control.